tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

Medexus Pharmaceuticals Announces $30 Million Public Offering
Company AnnouncementsMedexus Pharmaceuticals Announces $30 Million Public Offering
2d ago
Medexus Pharmaceuticals Launches Public Offering to Enhance Financial Flexibility
PremiumCompany Announcements
Medexus Pharmaceuticals Launches Public Offering to Enhance Financial Flexibility
3d ago
Medexus Secures FDA Approval for GRAFAPEX, Eyes $100M Revenue Milestone
PremiumCompany Announcements
Medexus Secures FDA Approval for GRAFAPEX, Eyes $100M Revenue Milestone
8d ago
Medexus Secures BC Reimbursement for Trecondyv
PremiumCompany Announcements
Medexus Secures BC Reimbursement for Trecondyv
15d ago
Medexus Pharmaceuticals Secures Deal for Trecondyv in Canada
PremiumCompany Announcements
Medexus Pharmaceuticals Secures Deal for Trecondyv in Canada
2M ago
Medexus Pharmaceuticals Reports Strong Q2 2025 Results
PremiumCompany AnnouncementsMedexus Pharmaceuticals Reports Strong Q2 2025 Results
3M ago
Medexus Shareholders Show Strong Support at Annual Meeting
Premium
Company Announcements
Medexus Shareholders Show Strong Support at Annual Meeting
4M ago
Medexus Awaits FDA Decision on Treosulfan After Delay
Premium
Company Announcements
Medexus Awaits FDA Decision on Treosulfan After Delay
5M ago
Medexus Pharmaceuticals Reports Mixed Q1 2025 Results
PremiumCompany Announcements
Medexus Pharmaceuticals Reports Mixed Q1 2025 Results
6M ago
Is MDP a Buy, Before Earnings?
PremiumPre-Earnings
Is MDP a Buy, Before Earnings?
6M ago
Medexus Pharmaceuticals Schedules Q1 2025 Earnings Call
PremiumCompany Announcements
Medexus Pharmaceuticals Schedules Q1 2025 Earnings Call
6M ago
Medexus Pharmaceuticals Hits Record Revenue
PremiumCompany Announcements
Medexus Pharmaceuticals Hits Record Revenue
7M ago
MDP Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsMDP Earnings Report this Week: Is It a Buy, Ahead of Earnings?
7M ago
Medexus Pharmaceuticals Announces Upcoming Earnings Call
Premium
Company Announcements
Medexus Pharmaceuticals Announces Upcoming Earnings Call
8M ago
Medexus Awaits FDA Decision on Treosulfan
Premium
Company Announcements
Medexus Awaits FDA Decision on Treosulfan
8M ago
Medexus Pharmaceuticals Accepts Metoject® Ruling
PremiumCompany Announcements
Medexus Pharmaceuticals Accepts Metoject® Ruling
9M ago
Medexus Pharmaceuticals Shines at Investor Conference
PremiumCompany Announcements
Medexus Pharmaceuticals Shines at Investor Conference
10M ago
Medexus’s Hemophilia B Drug Now Pediatric-Approved
PremiumCompany Announcements
Medexus’s Hemophilia B Drug Now Pediatric-Approved
10M ago
MDP Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
MDP Earnings Report this Week: Is It a Buy, Ahead of Earnings?
12M ago
Is MDP a Buy, Before Earnings?
PremiumPre-EarningsIs MDP a Buy, Before Earnings?
1y ago
Medexus Pharmaceuticals (MDP) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Medexus Pharmaceuticals (MDP) Q4 Earnings Cheat Sheet
2y ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >